Sprites
Donnerstag, 23.05.2013Börsentäglich über 11.000 News von 441 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

ONCOGENEX PHARMACEUTICALS INC

WKN: A0Q8G8  ISIN: US68230A1060  Ticker-Symbol: SP4A 
Aktie:
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ONCOGENEX PHARMACEUTICALS INC Chart 1 Jahr
1-Woche-Intraday-Chart
ONCOGENEX PHARMACEUTICALS INC 1-Woche-Intraday-Chart
Aktuelle News zur ONCOGENEX PHARMACEUTICALS Aktie
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
13:16-
12:40-
12:3234
BOTHELL, Wash.and VANCOUVER, British Columbia, May 23, 2013 /PRNewswire/ --OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced plans for the initiation of the Cedar' clinical trial, an...
Mehr lesen zu:
OncoGenex Announces Plans for the Initiation of the Cedar' Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer
22.05.25
BOTHELL, Wash. and VANCOUVER, British Columbia, May 22, 2013 /PRNewswire/ --OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), a leader in the development of novel therapeutics to target mechanisms of...
Mehr lesen zu:
OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting
03.05.-
02.05.-
02.05.16
BOTHELL, Wash. and VANCOUVER, British Columbia, May 2, 2013 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today provided an overview of clinical development activities for its two...
Mehr lesen zu:
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
01.05.1
01.05.-
01.05.-
01.05.59
BOTHELL, Wash. and VANCOUVER, British Columbia, May 1, 2013 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced plans for the initiation of the Rainier' trial, an investigator-sponsored...
Mehr lesen zu:
OncoGenex Announces Plans for the Initiation of the Rainier' Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE plus Gemcitabine in Patients with Metastatic Pancreatic Cancer
30.04.-
30.04.27
BOTHELL, Wash. and VANCOUVER, British Columbia, April 30, 2013 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced initiation of the Borealis-2' clinical trial, an investigator-sponsored...
Mehr lesen zu:
OncoGenex Announces that the Borealis-2' Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment
25.04.16
BOTHELL, WA and VANCOUVER, BC, April 25, 2013 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's first quarter 2013 financial results will be released...
Mehr lesen zu:
OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013
23.04.22
BOTHELL, WA and VANCOUVER, BC, April 23, 2013 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Scott Cormack, President and Chief Executive Officer, will provide...
Mehr lesen zu:
OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference
12.04.2
12.04.2
12.04.-
11.04.1
11.04.69
BOTHELL, Wash. and VANCOUVER, British Columbia, April 11, 2013 /PRNewswire/ --OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced plans for the initiation of the Spruce clinical trial,...
Mehr lesen zu:
OncoGenex Announces Plans for the Initiation of the Spruce' Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
Seite: 1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
ONCOGENEX PHARMACEUTICALS INC-Investoren interessieren sich auch für diese News

Unternehmen / AktienAktienkurs%Top-Nachrichten
INCYTE16,943-4,81 %Incyte Corporation CEO Presents at UBS Global Healthcare Conference (Transcript)
ISIS PHARMACEUTICALS15,459-1,84 %Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
TITAN PHARMACEUTICALS0,377-23,06 %Titan Pharmaceuticals Announces First Quarter 2013 Financial Results / Titan Management Team to Host Conference Call May 16 at 1:00 p.m. ET / 10:00 a.m. PT
PACIRA PHARMACEUTICALS22,209+1,46 %Pacira Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript
SYNTHETIC BIOLOGICS1,073-0,56 %Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference
Lade...
Aufklappen
Schliessen